Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Mar 14;8(3):e020270.
doi: 10.1136/bmjopen-2017-020270.

Factors associated with polypharmacy in primary care: a cross-sectional analysis of data from The English Longitudinal Study of Ageing (ELSA)

Natasha Slater  1 , Simon White  1 , Rebecca Venables  1 , Martin Frisher  1
Affiliations

Factors associated with polypharmacy in primary care: a cross-sectional analysis of data from The English Longitudinal Study of Ageing (ELSA)

Natasha Slater et al. BMJ Open. .

Abstract

Objectives: While older age and ill health are known to be associated with polypharmacy, this paper aims to identify whether wealth, body mass index (BMI), smoking and alcohol consumption are also associated with polypharmacy (5-9 prescribed medications) and hyperpolypharmacy prevalence (≥10 prescribed medications), among older people living in England.

Design: Cross-sectional study.

Setting: The English Longitudinal Study of Ageing Wave 6 (2012-2013).

Participants: 7730 participants aged over 50 years.

Data synthesis: Two multivariate models were created. HR with corresponding 95% CI, for polypharmacy and hyperpolypharmacy, were calculated after adjusting for gender, age, wealth, smoking, alcohol consumption, BMI, self-rated health and the presence of a chronic health condition.

Results: Lower wealth (lowest wealth quintile vs highest wealth quintile, adjusted HR 1.28; 95% CI 1.04 to 1.69, P=0.02) and obesity (adjusted HR 1.81; 95% CI 1.53 to 2.15, p<0.01) were significantly associated with polypharmacy. Increasing age (50-59 years vs 70-79 years, adjusted HR 3.42; 95% CI 2.81 to 4.77, p<0.01) and the presence of a chronic health condition (adjusted HR 2.94; 95% CI 2.55 to 3.39, p<0.01) were also associated with polypharmacy. No statistically significant association between smoking and polypharmacy (adjusted HR 1.06; 95% CI 0.86 to 1.29, P=0.56) was established; while, very frequent alcohol consumption (consuming alcohol >5 times per week) was inversely associated with polypharmacy (never drank alcohol vs very frequently, adjusted HR 0.64; 95% CI 0.52 to 0.78, p<0.01). The adjusted HR for hyperpolypharmacy was accentuated, compared with polypharmacy.

Conclusion: This study has identified that lower wealth, obesity, increasing age and chronic health conditions are significantly associated with polypharmacy and hyperpolypharmacy prevalence. The effect of these factors, on polypharmacy and especially hyperpolypharmacy prevalence, is likely to become more pronounced with the widening gap in UK wealth inequalities, the current obesity epidemic and the growing population of older people. The alcohol findings contribute to the debate on the relationship between alcohol consumption and health.

Keywords: demography; longitudinal; older people; polypharmacy.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Bivariate correlations between polypharmacy and covariates. BMI, body mass index.
See this image and copyright information in PMC

References

    1. Duerden M, Payne R. Polypharmacy - what is it and how common is it? Prescriber 2014;25:44–7. 10.1002/psb.1274 - DOI
    1. O’Dwyer M, Peklar J, McCallion P, et al. . Factors associated with polypharmacy and excessive polypharmacy in older people with intellectual disability differ from the general population: a cross-sectional observational nationwide study. BMJ Open 2016;6:e010505 10.1136/bmjopen-2015-010505 - DOI - PMC - PubMed
    1. Guthrie B, Makubate B, Hernandez-Santiago V, et al. . The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995-2010. BMC Med 2015;13:74 10.1186/s12916-015-0322-7 - DOI - PMC - PubMed
    1. The Dynamics of Ageing. Evidence from the English Longitudinal Study of Ageing (Wave 7).2002–15 www.ifs.org.uk/uploads/elsa/docs_w7/report.pdf (accessed 27 Jul 2017).
    1. Department of Health. Long Term Condition Compendium of Information. Third Edition, 2012. www.gov.uk/government/uploads/attachment_data/file/216528/dh_134486.pdf (accessed 27 Jul 2017).